Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-02-23

FDA Approved: LABETALOL HYDROCHLORIDE — Supplemental Application (Method Pharmaceuticals, LLC)

View source ↗

Summary

The FDA approves a supplemental application for labetalol hydrochloride from Method Pharmaceuticals, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Labetalol Hydrochloride (Labetalol hydrochloride)

Snippet

SUPPL AP for LABETALOL HYDROCHLORIDE (LABETALOL HYDROCHLORIDE)